TRANSCENTA
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.
TRANSCENTA
Industry:
Biopharma Biotechnology
Founded:
2019-01-01
Address:
Huangpu, Shanghai, China
Country:
China
Website Url:
http://www.transcenta.com
Total Employee:
101+
Status:
Active
Contact:
0571-28279502
Total Funding:
342 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Tag Manager Google Analytics SSL By Default Global Site Tag Mobile Non Scaleable Content Google Analytics 4
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Steakholder Foods
Steakholder Foods is a leading innovator in alternative proteins production and 3D printing production technologies.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
RWDC Industries
RWDC Industries develops sustainable biodegradable solutions, with a focus on biodegradable, water-based coatings for paper-based packaging.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Solugen
Solugen is a specialty chemicals manufacturer creating chemistries that are safe, cost-effective, and environmentally-friendly.
Current Advisors List
Board_member
2022-12-01
Current Employees Featured
Xueming Qian Co-Founder & CEO @ Transcenta
Co-Founder & CEO
2019-01-01
Daniel Weng CFO @ Transcenta
CFO
2021-12-01
Jonathan Zhao Co-founder & Executive Chairman @ Transcenta
Co-founder & Executive Chairman
2015-03-01
Caroline Germa Executive Vice President, Global Medicine Development and Chief Medical Officer @ Transcenta
Executive Vice President, Global Medicine Development and Chief Medical Officer
2022-08-01
Chris Hwang CTO @ Transcenta
CTO
Frank Ye COO @ Transcenta
COO
Yining Zhao Co-Founder and Chairman of the Board @ Transcenta
Co-Founder and Chairman of the Board
2015-03-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-02 | Hangzhou Just Biotherapeutics (Just China) | Hangzhou Just Biotherapeutics (Just China) acquired by Transcenta | N/A |
| 2019-01-02 | MabSpace Biosciences | MabSpace Biosciences acquired by Transcenta | N/A |
Investors List
Temasek Foundation
Temasek Foundation investment in Post-IPO Equity - Transcenta
ARCH Venture Partners
ARCH Venture Partners investment in Post-IPO Equity - Transcenta
Lilly Asia Ventures
Lilly Asia Ventures investment in Post-IPO Equity - Transcenta
Teng Yue Partners
Teng Yue Partners investment in Post-IPO Equity - Transcenta
Sequoia Capital
Sequoia Capital investment in Post-IPO Equity - Transcenta
China Merchants Fund
China Merchants Fund investment in Series C - Transcenta
Country Garden Venture Capital
Country Garden Venture Capital investment in Series C - Transcenta
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Transcenta
China Structural Reform Fund
China Structural Reform Fund investment in Series C - Transcenta
Richland Equities
Richland Equities investment in Series C - Transcenta
Key Employee Changes
Official Site Inspections
http://www.transcenta.com Semrush global rank: 8.25 M Semrush visits lastest month: 596
- Host name: 106.14.136.153
- IP address: 106.14.136.153
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Transcenta"
About Us-TRANSCENTA HOLDING - A Global Fully Integrated …
On September 29, 2021, Transcenta was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 06628. Transcenta has established global footprint, with …See details»
Transcenta - Crunchbase Company Profile & Funding
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative …See details»
Transcenta - LinkedIn
Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing.See details»
Investors | TRANSCENTA HOLDING | A global Fully …
4 days ago Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing. On September 29, 2021, Transcenta was listed on the Main …See details»
Transcenta Announces the Appointment of Dr. Caroline Germa as …
SUZHOU, China, Aug. 8, 2022 -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, …See details»
COMPANY PRESENTATION - TRANSCENTA
GC182: Transcenta produced based on publicly available information. 40x 82(0.2 μ l) HEK293/CLDN18.1 cell HEK293/CLDN18.2 cell 11(0.15 μ l) CLDN18.2 14G11 CDx …See details»
Transcenta - Updates, News, Events, Signals & Triggers - Crunchbase
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture. Search Crunchbase Start Free TrialSee details»
Financial Reports | TRANSCENTA HOLDING | A global Fully …
Public Relations: pr@transcenta.com Investor Relations: ir@transcenta.com Business Development: bd@transcenta.comSee details»
Transcenta - VentureRadar
Transcenta has established a pipeline of over ten innovative molecules in oncology, bone disorders and nephrology. Most of these are discovered and developed in house and some …See details»
全球创新-创胜集团 - 全整合型国际化生物 ... - TRANSCENTA
T-bloc. 创胜集团位于杭州医药港的gmp生产基地采用拥有自主知识产权的模块化理念进行设计。 该模块化gmp设施t-bloc具有高度的灵活性和可扩展性；生产基地设计之初便将产品安全和工艺 …See details»
Clinical Development-TRANSCENTA HOLDING - A Global Fully …
A global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing.See details»
Transcenta Therapeutics Co., Limited (Transcenta Therapeutics Co ...
了解Transcenta Therapeutics Co., Limited (Transcenta Therapeutics Co., Limited)公司的药物管线，治疗领域，技术平台，以及它的15项临床试验, 74篇新闻和15篇文献，疾病领域:肿瘤，内分 …See details»
transcenta holding limited News & Press Releases - PR Newswire
Dec 13, 2024 News from transcenta holding limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, …See details»
Transcenta Received IND Clearance from FDA for Its Best-In-Class …
SUZHOU, China, Oct. 5, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in …See details»
Innovation-TRANSCENTA HOLDING - A Global Fully Integrated ...
In Transcenta, our CMC team comprises competent SMEs from various functions spanning all aspects of biologics development. Supported by Integrated Continuous Bioprocessing …See details»
Transcenta Reviews: What Is It Like to Work At Transcenta?
2 Transcenta reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»
A Phase I Clinical Trial to Evaluate the Safety ... - TRANSCENTA
Transcenta has established a pipeline of over 10 biologics programs in oncology, bone disorders and nephrology, many of which have entered clinical trials. A Phase I Clinical Trial to Evaluate …See details»
Transcenta AKTIE | News | Aktienkurs | Dividende | Chart
Mar 11, 2025 Transcenta Aktie - Hier finden Sie: Transcenta Aktienkurs aktuell, Kurs, Chart und alle Kennzahlen für die Transcenta Aktie.See details»
Transcenta Announces First Patient Dosed in the U.S. Study of Its …
March. 23, 2023, Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, …See details»
Sample j#rH - TRANSCENTA
Please read carefully the prospectus of Transcenta Holding Limited (the “Company”) dated September 14, 2021 (the “Prospectus”) (in particular, the section on How to Apply for Hong …See details»